Commerzbank Aktiengesellschaft Mannkind Corp Transaction History

Commerzbank Aktiengesellschaft

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 17, 2020	SELL	$1.14 - $1.49 $25,244 - $32,994	-22,144 Closed	0 $0
Q3 2019 Oct 03, 2024	BUY	$1.04 - $1.44 $23,029 - $31,887	22,144 New	22,144 $28,000
Q2 2019 Oct 03, 2024	BUY	$1.09 - $1.88 $24,136 - $41,630	22,144 New	22,144 $25,000
Q1 2019 Oct 03, 2024	BUY	$1.14 - $2.25 $25,244 - $49,824	22,144 New	22,144 $44,000
Q4 2018 Oct 03, 2024	BUY	$1.02 - $2.05 $22,586 - $45,395	22,144 New	22,144 $23,000
Q3 2018 Oct 04, 2024	BUY	$1.01 - $2.19 $22,365 - $48,495	22,144 New	22,144 $41,000
Q2 2018 Oct 04, 2024	BUY	$1.59 - $2.38 $35,208 - $52,702	22,144 New	22,144 $42,000
Q4 2017 Oct 04, 2024	BUY	$2.28 - $6.71 $50,488 - $148,586	22,144 New	22,144 $51,000
Q3 2017 Nov 13, 2017	SELL	$1.15 - $2.29 $3,440 - $6,851	-2,992 Reduced 11.9%	22,144 $48,000
Q2 2017 Aug 09, 2017	BUY	N/A	25,136	25,136 $35,000

243

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.